L04AA03 • human anti-lymphocyte immunoglobulin • Antineoplastic and immunomodulating agents | Immunosuppressants | Selective immunosuppressants
Human anti-lymphocyte immunoglobulin is used for the prevention and treatment of acute rejection in organ transplantation. It works by suppressing the body's immune response, reducing T-lymphocyte activity.
The medication is administered intravenously, as directed by a doctor. It is important to monitor the patient for adverse reactions during the infusion.
Side effects may include fever, chills, skin rashes, or injection site reactions. In rare cases, severe allergic reactions or opportunistic infections may occur.
Human anti-lymphocyte immunoglobulin is not recommended for patients with hypersensitivity to human plasma proteins or active severe infections.
Substance: human anti-lymphocyte immunoglobulin
Date of last drug list: 01-07-2013
Commercial code: W13433001
Concentration: 20mg / ml
Pharmaceutical form: infusion solution
Quantity: 1
Product type: generic
Prescription restrictions: S - Medicines prescription reserved for use in certain specialized fields.